The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Analysis of serum vitamin D levels and prognosis in stage III colon carcinoma patients treated with adjuvant FOLFOX+/- cetuximab chemotherapy: NCCTG N0147 (Alliance).
 
Frank A. Sinicrope
Stock and Other Ownership Interests - Gilead Sciences; illumina
Consulting or Advisory Role - EMD Serono; Ventana Medical Systems
Travel, Accommodations, Expenses - ventana medical systems
 
Qian Shi
No Relationships to Disclose
 
Thomas C. Smyrk
No Relationships to Disclose
 
Richard M. Goldberg
Honoraria - Baxter; Biothera; Forty Seven; Immunocare Therapies; Immunovative Therapies; kanghong Pharma; Merck; Merrimack; Momenta Pharmaceuticals; Novo Nordisk; Pfizer; Sirtex Medical; Taiho Pharmaceutical; Targovax
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Merck (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Baxter; Merck KGaA; Sanofi
 
Erica N Heying
No Relationships to Disclose
 
Steven J. Cohen
Consulting or Advisory Role - Bayer; Celgene; Genentech; Taiho Pharmaceutical
 
Sharlene Gill
Honoraria - celgene; Lilly
Consulting or Advisory Role - Celgene; Lilly; Shire; Taiho Pharmaceutical
Research Funding - Celgene
 
Morton S. Kahlenberg
No Relationships to Disclose
 
Suresh Nair
No Relationships to Disclose
 
Anthony Frank Shields
Employment - Benchling (I)
Stock and Other Ownership Interests - Benchling (I)
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Endocyte; GE Healthcare; Merck; Merrimack; Personal Genome Diagnostics; Siemens Healthcare Diagnostics; Taiho Pharmaceutical
Speakers' Bureau - GE Healthcare
Research Funding - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Life Sciences; Eisai; H3 Biomedicine; Inovio Pharmaceuticals; Karyopharm Therapeutics; Merrimack; Novartis; OncoMed; Plexxikon; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Caris Life Sciences; Endocyte; GE Healthcare; Merrimack
 
Daniel J. Sargent
Consulting or Advisory Role - Abbvie; Acerta Pharma; ARIAD; Astellas Pharma; AstraZeneca/MedImmune; Biothera; Celldex; Exelixis; Genentech; Incyte; Kyowa Hakko Kirin; Medivation; Merck; Merrimack; Nektar; Novartis; Pharmacyclics; Pique; Spiration; Xbiotech
Research Funding - Celgene (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Celgene
 
Balkrishna N. Jahagirdar
No Relationships to Disclose
 
Michael N. Pollak
No Relationships to Disclose
 
Steven R. Alberts
No Relationships to Disclose